ArticleFrontiers in immunology2022

A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis.

Konstantinos Lazaridis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.